Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 153 participants.
Also called NCT03140631
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 153 participants
- Sponsor
- Registry
-
NCT03140631
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03140631. Randomized; no masking; primary purpose treatment. Start 2017-03-23 (actual); primary completion 2017-11-16 (actual). Results posted on 2018-10-23.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation
- Condition
- Atrial Fibrillation
- Condition
- Catheter Ablation
- Intervention (Drug)
- Protamine Sulfate
- Lead sponsor
- University of Michigan
Record details
- Record id
cardio:ct-nct03140631- Content hash
c562626d186c1886369489cd90ae9ed56f676f038ca83b551e335d143e4f70fa